ATL Technology Expands Operations in Costa Rica

Divests CRI Business Unit

ATL Technology, an interconnect development and manufacturing partner of top medical device firms, today announced the expansion of its Costa Rica operations and the divestiture of its Catheter Research Inc. (“CRI”) business unit to Biomerics.

ATL Technology Brad Brown and CEO notes, “With the increase in interconnect manufacturing demand in Costa Rica, we wanted to put ourselves in a better position to serve our customers and live our mission of bringing impactful medical devices to market. This expansion will help us do that.”

The expansion, which will add over 9,000 sq. ft. of manufacturing space, is one step in the company’s Technology strategic Costa Rica growth plan.

The company has been operating in Costa Rica since 2013. Since that time, the operations have grown to include over 85 employees and 22,000 sq. ft. of manufacturing space, helping supply some of the top medical device companies in the world with cutting-edge interconnect solutions.

This announcement comes on the heels of their decision to divest its CRI business unit.

CRI, a manufacturer of interventional catheters and medical device assemblies with locations in Costa Rica and Indiana, was purchased by the company in a joint venture with Biomerics in 2018.

“Acquiring and running CRI enabled us to learn some valuable lessons about catheter development and manufacturing, which we can use to help our customers moving forward,” explained Brad. “We plan on investing the proceeds from the sale in our internal R&D and growth initiatives.”

To celebrate the Costa Rica expansion, ATL will be hosting an open house on Friday, January 24. The open house will be by invitation only.

The company will also be discussing the plant expansion, the future of interconnect systems, and the latest medical device technology at its exclusive event, #BeyondWest, at MD&M West in February. To enter for your chance to attend

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version